Why the study?
Does thoracic endovascular aortic repair (TEVAR) improve outcomes in patients with acute complicated and uncomplicated type B aortic dissection?
Does thoracic endovascular aortic repair (TEVAR) improve outcomes in patients with acute complicated and uncomplicated type B aortic dissection?
TEVAR has revolutionized the treatment of complicated type B aortic dissection with lower early mortality than open surgery, and it promotes favorable aortic remodeling in uncomplicated cases, though its routine use in uncomplicated dissection requires further long-term evidence.
May support TEVAR preference over open repair in complicated type B dissection; leaves open routine use versus medical therapy in uncomplicated cases.
The treatment of acute type B aortic dissection is a rapidly evolving field, due in a large part to the advent of thoracic endovascular aortic repair (TEVAR). This review will summarize the current literature on the management of both complicated and uncomplicated type B dissections, with special attention paid to emerging evidence supporting earlier aggressive treatment.
No takes yet. Share an insight, caveat, or question.
Eric S. Weiss (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: